• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Claritev and Burjeel Holdings Partner to Advance Revenue Integrity Solutions in the MENA Region

    4/25/25 8:00:00 AM ET
    $CTEV
    Business Services
    Consumer Discretionary
    Get the next $CTEV alert in real time by email

    Claritev and Claims Care Revenue Cycle Management, a Burjeel Holdings Company, sign an MoU to bring the US-based Claritev's solutions to the MENA region and collaborate on revenue cycle management capabilities

    Claritev Corporation ("Claritev") (NYSE:CTEV) and Claims Care Revenue Cycle Management LLC ("Claims Care" or "CCRCM"), a division of Burjeel Holdings (ADX: BURJEEL), have signed a memorandum of understanding (MOU) to leverage Claritev's Payment and Revenue Integrity solutions for the Middle East and North Africa regional payer market and create a joint product roadmap to offer advanced revenue cycle management (RCM) capabilities in the region.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250424067343/en/

    This collaboration brings two industry leaders from the U.S. and MENA markets together, with an aim to offer innovation and technology that promotes affordable, transparent and higher quality healthcare services. The partnership also marks a significant milestone in Claritev's mission to expand its footprint globally and offer its highly scalable products to new markets.

    Under the terms of the MOU, Claritev and Claims Care will combine their resources, domain expertise and regional networks to co-create transformative RCM offerings. These solutions will incorporate Claritev's capabilities in Advanced Code Editing and Decision Science with Claims Care's deep expertise and regional leadership in revenue cycle management to streamline the reimbursement process. The alliance also involves the transition of certain offshore business processes to Claims Care, further deepening operational synergies and market alignment.

    "At Burjeel Holdings, we are constantly exploring ways to elevate healthcare delivery through innovation and strategic collaboration. Our partnership with Claritev marks a major step toward transforming revenue cycle management in MENA. By integrating Claritev's world-class technology with Claims Care's deep market expertise, we aim to drive greater efficiency, transparency and value across the healthcare ecosystem," said John Sunil, Group CEO, Burjeel Holdings.

    "Global healthcare is at an inflection point and we are uniquely positioned to transform it with technology and data," said Travis Dalton, Chairman, CEO and President of Claritev. He continued, "Claims Care is one of the largest RCM providers in the Middle East, a key component of Burjeel Holding's integrated healthcare network, and most importantly, is aligned with our vision of providing innovative solutions across the healthcare ecosystem."

    About Claritev

    Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists, and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency, and optimizes networks and benefits design in healthcare. By developing purpose-build solutions that support all key stakeholders – including payors, employers, patients, providers and third parties – Claritev is dedicated to making healthcare more accessible and affordable for all.

    Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

    About Claims Care Revenue Cycle Management LLC

    Established in 2016, Claims Care Revenue Cycle Management (Claims Care) is one of the largest independent revenue cycle management providers in the MENA region. Operating under Burjeel Holdings—a leading superspecialty healthcare services provider in the MENA region and listed on the Abu Dhabi Securities Exchange (ADX)—Claims Care has 1,000 employees across four international locations and operates highly automated, complex billing and claims management systems. Leveraging AI-based coding, resubmission, paperless authorization, analytical dashboards, and RPA-assisted eligibility verification, Claims Care manages over 3.5 million records, 5.4 million claims, and 1500+ key contracts. Comprehensive solutions span from patient registration to reimbursement. Additional offerings include medical transcription, business and revenue intelligence analytics, and quality assurance audits. Through partnerships with leading insurers, Claims Care is committed to streamlining administrative workflows and strengthening the delivery of patient-centered care across the region.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250424067343/en/

    Media Relations

    Pamela Walker

    VP, Corporate Marketing

    Claritev

    781-895-3118

    [email protected]

    Investor Relations

    Jason Wong

    SVP, Treasury & Investor Relations

    Claritev

    866-909-7427

    [email protected]

    Shawna Gasik

    AVP, Investor Relations

    Claritev

    866-909-7427

    [email protected]

    Get the next $CTEV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    5/29/2025$44.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CTEV
    SEC Filings

    See more
    • SEC Form S-8 filed by Claritev Corporation

      S-8 - Claritev Corp (0001793229) (Filer)

      5/9/25 8:05:24 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Claritev Corporation

      10-Q - Claritev Corp (0001793229) (Filer)

      5/9/25 7:40:59 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Claritev Corp (0001793229) (Filer)

      5/8/25 6:04:59 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Chief Operating Officer Hogge Jerome bought $349,250 worth of shares (12,500 units at $27.94), increasing direct ownership by 17% to 84,402 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:24:37 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • EVP&CFO Garis Douglas Michael bought $99,828 worth of shares (3,600 units at $27.73), increasing direct ownership by 3% to 143,861 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:23:54 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Pres., CEO & Executive Chair Dalton Travis bought $99,984 worth of shares (3,773 units at $26.50), increasing direct ownership by 2% to 243,058 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/16/25 4:23:45 PM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Financials

    Live finance-specific insights

    See more
    • Claritev Corporation Reports First Quarter 2025 Results

      – Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a

      5/8/25 6:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation Announces First Quarter 2025 Earnings Conference Call

      Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadshow.com/events/login?show=fda0

      4/10/25 8:30:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations

      Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US Claritev Corporation ("Claritev") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ("MENA") region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology soluti

      5/28/25 8:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev and Burjeel Holdings Finalize Strategic Collaboration, Marks Claritev's Expansion into the Middle East

      This agreement follows the previous announcement of a memorandum of understanding signed last month. Claritev Corporation ("Claritev") (NYSE:CTEV) and Claims Care Revenue Cycle Management LLC ("Claims Care" or "CCRCM"), a division of Burjeel Holdings (ADX: BURJEEL), are pleased to announce the formalization of their strategic relationship, following the signing of a memorandum of understanding ("MoU") announced last month. This collaboration aims to revolutionize revenue cycle management ("RCM") in the Middle East and North Africa ("MENA") region by bringing the power of Claritev's advanced claims analytics and AI-driven solutions together with Claims Care's extensive regional expertise.

      5/22/25 10:45:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation Reports First Quarter 2025 Results

      – Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a

      5/8/25 6:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Chief Operating Officer Hogge Jerome bought $349,250 worth of shares (12,500 units at $27.94), increasing direct ownership by 17% to 84,402 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:24:37 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • EVP&CFO Garis Douglas Michael bought $99,828 worth of shares (3,600 units at $27.73), increasing direct ownership by 3% to 143,861 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:23:54 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Pres., CEO & Executive Chair Dalton Travis bought $99,984 worth of shares (3,773 units at $26.50), increasing direct ownership by 2% to 243,058 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/16/25 4:23:45 PM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Leadership Updates

    Live Leadership Updates

    See more
    • Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations

      Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US Claritev Corporation ("Claritev") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ("MENA") region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology soluti

      5/28/25 8:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

      HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

      5/6/25 10:02:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Appoints Jason Kap to its Board of Directors

      Board gains deep technology and innovation expertise to support Claritev's tech-driven growth strategy Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, yesterday announced the appointment of Jason Kap to its Board of Directors, effective immediately following his election at the Company's Annual Meeting of Shareholders on April 30, 2025. Kap brings more than two decades of leadership experience driving technology, pricing and product transformation strategies across the software and services industries, strengthening Claritev's focus on building a next-generati

      5/1/25 8:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Claritev upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Claritev from Neutral to Overweight and set a new price target of $44.00

      5/29/25 8:13:13 AM ET
      $CTEV
      Business Services
      Consumer Discretionary